AKT Stock Overview
Operates hospitals in Morocco. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 6/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Akdital S.A Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | د.م1,086.00 |
52 Week High | د.م1,144.00 |
52 Week Low | د.م480.00 |
Beta | 0 |
11 Month Change | 6.26% |
3 Month Change | 17.41% |
1 Year Change | 120.73% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 259.60% |
Recent News & Updates
Recent updates
Shareholder Returns
AKT | MA Healthcare | MA Market | |
---|---|---|---|
7D | 2.4% | 0.2% | 1.6% |
1Y | 120.7% | 29.7% | 22.5% |
Return vs Industry: AKT exceeded the MA Healthcare industry which returned 29.7% over the past year.
Return vs Market: AKT exceeded the MA Market which returned 22.5% over the past year.
Price Volatility
AKT volatility | |
---|---|
AKT Average Weekly Movement | 3.6% |
Healthcare Industry Average Movement | 4.1% |
Market Average Movement | 4.5% |
10% most volatile stocks in MA Market | 8.1% |
10% least volatile stocks in MA Market | 2.4% |
Stable Share Price: AKT has not had significant price volatility in the past 3 months compared to the MA market.
Volatility Over Time: AKT's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2011 | 3,907 | Rochdi Talib | akdital.ma |
Akdital S.A operates hospitals in Morocco. Its portfolio of treatments includes surgery, oncology, cardiology, maternity, and radiology, as well as multidisciplinary healthcare facilities. It operates private hospitals, multidisciplinary, and specialized clinics and oncology centers.
Akdital S.A Fundamentals Summary
AKT fundamental statistics | |
---|---|
Market cap | د.م15.38b |
Earnings (TTM) | د.م220.64m |
Revenue (TTM) | د.م2.33b |
69.7x
P/E Ratio6.6x
P/S RatioIs AKT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AKT income statement (TTM) | |
---|---|
Revenue | د.م2.33b |
Cost of Revenue | د.م1.66b |
Gross Profit | د.م669.64m |
Other Expenses | د.م449.00m |
Earnings | د.م220.64m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 15.58 |
Gross Margin | 28.76% |
Net Profit Margin | 9.48% |
Debt/Equity Ratio | 58.6% |
How did AKT perform over the long term?
See historical performance and comparison